Timo Lappalainen appointed a Professor of Practice of pharmaceutical industry at the InFLAMES Flagship 16 January 2024
Cancer therapy bexmarilimab awakens immune cells to attack tumours that have avoided the detection of the immune system 7 December 2023
Unlocking the secrets of cell behaviour on soft substrates: A paradigm shift in mechanobiology 18 October 2023
